Tech Company Financing Transactions

Sound Pharmaceuticals Funding Round

On 10/16/2013, Sound Pharmaceuticals raised $6 million in investment from private investors.

Transaction Overview

Announced On
10/16/2013
Transaction Type
Venture Equity
Amount
$6,048,261
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Not a solicitation.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4010 Stone Way N 120
Seattle, WA 98103
USA
Email Address
Overview
Sound Pharmaceuticals (SPI) is a privately held biopharmaceutical company in Seattle, WA. Our goal is to develop prescription drugs that will enable doctors and patients to prevent and treat hearing loss, a disease that affects over 30 to 40 million Americans.
Profile
Sound Pharmaceuticals LinkedIn Company Profile
Social Media
Sound Pharmaceuticals Company Twitter Account
Company News
Sound Pharmaceuticals News
Facebook
Sound Pharmaceuticals on Facebook
YouTube
Sound Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Jonathan Kil
  Jonathan Kil LinkedIn Profile  Jonathan Kil Twitter Account  Jonathan Kil News  Jonathan Kil on Facebook
Chief Scientific Officer
Eric Lynch
  Eric Lynch LinkedIn Profile  Eric Lynch Twitter Account  Eric Lynch News  Eric Lynch on Facebook
VP - Operations
Paul Hoskins
  Paul Hoskins LinkedIn Profile  Paul Hoskins Twitter Account  Paul Hoskins News  Paul Hoskins on Facebook


 

 

Browse more venture capital transactions:

Prev: 10/16/2013: Sofie BioSciences venture capital transaction
Next: 10/16/2013: PolicyMic venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary